Skip to main content

Advertisement

Log in

Regulation of MMP 2 and MMP 9 expressions modulated by AP-1 (c-jun) in wound healing: improving role of Lucilia sericata in diabetic rats

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aims

Lucilia sericata larvae have been successfully used on healing of wounds in the diabetics. However, the involvement of the extraction/secretion (ES) products of larvae in the treatment of diabetic wounds is still unknown. Activator protein-1 (AP-1) transcription, composed of c-jun and c-Fos proteins, has been shown to be the principal regulator of multiple MMP transcriptions under a variety of conditions, also in diabetic wounds. Specifically, MMP-2 and MMP-9’s transcriptions are known to be modulated by AP-1. c-jun has been demonstrated to be a repressor of p53 in immortalized fibroblasts. The aim of the present study is to investigate the effects of L. sericata ES on the expression of AP-1 (c-jun), p53, MMP-2, and MMP-9 in wound biopsies dissected from streptozotocin induced diabetic rats.

Methods

The expression levels of MMP-2, MMP-9, c-jun and p53 in dermal tissues were determined at days 0, 3, 7 and 14 after wounding, using immunohistochemical analysis and quantitative real-time PCR.

Results

The treatment with ES significantly decreased through inflammation-based induction of MMP-2 and MMP-9 expression levels in the wounds of diabetic groups, compared to control groups at the third day of wound healing. At the 14th day, there were dramatic decreases in expression of c-jun, MMP-9, and p53 in ES-treated groups, compared to the diabetic group (P < 0.001, P < 0.05 and P < 0.01, respectively).

Conclusion

ES products of L. sericata may enhance the process of wound healing in phases of inflammation, proliferation, and re-epithelization, essentially via regulating c-jun expression and modulating MMP-2 and MMP-9 expressions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Wall SJ, Bevan D, Thomas DW et al (2002) Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J Investig Dermatol 119(1):91–98

    Article  CAS  PubMed  Google Scholar 

  2. Martins VL, Caley M, O’Toole EA (2013) Matrix metalloproteinases and epidermal wound repair. Cell Tissue Res 351(2):255–268

    Article  CAS  PubMed  Google Scholar 

  3. Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 1825(1):29–36

    CAS  PubMed  Google Scholar 

  4. Salo T, Mäkelä M, Kylmäniemi M, Autio-Harmainen H, Larjava H (1994) Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Investig J Tech Methods Pathol 70(2):176–182

    CAS  Google Scholar 

  5. Bond M, Fabunmi RP, Baker AH, Newby AC (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-κB. FEBS Lett 435(1):29–34

    Article  CAS  PubMed  Google Scholar 

  6. Qin Z, Balimunkwe RM, Quan T (2017) Age-related reduction of dermal fibroblast size upregulates multiple matrix metalloproteinases as observed in aged human skin in vivo. Br J Dermatol 177(5):1337–1348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sato H, Seiki M (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8(2):395–405

    CAS  PubMed  Google Scholar 

  8. Benbow U, Brinckerhoff CE (1997) The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15(8–9):519–526

    Article  CAS  PubMed  Google Scholar 

  9. Fini ME, Bartlett JD, Matsubara M et al (1994) The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription. J Biol Chem 269(46):28620–28628

    CAS  PubMed  Google Scholar 

  10. Yokoo T, Kitamura M (1996) Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am J Physiol 270(1 Pt 2):F123–F130

    CAS  PubMed  Google Scholar 

  11. Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20(19):2390–2400 (Review)

    Article  CAS  Google Scholar 

  12. Knaś M, Niczyporuk M, Zalewska A, Car H (2013) The unwounded skin remodeling in animal models of diabetes types 1 and 2. Physiol Res 62(5):519–526. (Epub 2013 Sep 10)

    PubMed  Google Scholar 

  13. Tombulturk FK, Kasap M, Tuncdemir M et al (2018) Effects of Lucilia sericata on wound healing in streptozotocin-induced diabetic rats and analysis of its secretome at the proteome level. Hum Exp Toxicol 37(5):508–520

    Article  CAS  PubMed  Google Scholar 

  14. Polat E, Aksöz İ, Arkan H, Coşkunpınar E, Akbaş F, Onaran İ (2014) Gene expression profiling of Lucilia sericata larvae extraction/secretion-treated skin wounds. Gene 550(2):223–229

    Article  CAS  PubMed  Google Scholar 

  15. Karipcin FS, Ensari TA, Kayisli UA, Guzel E, Kallen CB, Seli E (2011) The mRNA-binding protein HuR is regulated in the menstrual cycle and repressed in ectopic endometrium. Reprod Sci 18:145–155

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Pöppel AK, Kahl M, Baumann A et al (2016) A Jonah-like chymotrypsin from the therapeutic maggot Lucilia sericata plays a role in wound debridement and coagulation. Insect Biochem Mol Biol 70:138–147

    Article  CAS  PubMed  Google Scholar 

  17. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H (2002) Expression of matrix metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45(7):1011–1016

    Article  CAS  Google Scholar 

  18. Fisher GJ, Kang S, Varani J et al (2002) Mechanisms of photoaging and chronological skin aging. Arch Dermatol 138(11):1462–1470

    Article  CAS  PubMed  Google Scholar 

  19. Murakami H, Shimbo K, Inoue Y, Takino Y, Kobayashi H (2012) Importance of amino acid composition to improve skin collagen protein synthesis rates in UV-irradiated mice. Amino Acids 42(6):2481–2489

    Article  CAS  PubMed  Google Scholar 

  20. Fligiel SE, Varani J, Datta SC, Kang S, Fisher GJ, Voorhees JJ (2003) Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Investig Dermatol 120(5):842–848

    Article  CAS  PubMed  Google Scholar 

  21. Quan T, Qin Z, Xia W, Shao Y, Voorhees JJ, Fisher GJ (2009) Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc 14(1):20–24

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bian J, Sun Y (1997) Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17:6330–6338

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cohen M, Wuillemin C, Irion O, Bischof P (2008) Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells. Hum Reprod 23(10):2273–2281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Chung SW, Choi BM, Kim JY et al (2017) Altered gene and protein expressions in torn rotator cuff tendon tissues in diabetic patients. Arthroscopy 33(3):518–526

    Article  PubMed  Google Scholar 

  25. Anderson SS, Wu K, Nagase H, Stettler-Stevenson WG, Kim Y, Tsilibary EC (1996) Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells. Cell Adhes Commun 4(2):89–101

    Article  CAS  PubMed  Google Scholar 

  26. McLennan SV, Yue DK, Turtle JR (1998) Effect of glucose on matrix metalloproteinase activity in mesangial cells. Nephron 79(3):293–298

    Article  CAS  PubMed  Google Scholar 

  27. Desfaits AC, Serri O, Renier G (1998) Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care 21(4):487–493

    Article  CAS  PubMed  Google Scholar 

  28. Shiau MY, Tsai ST, Tsai KJ, Haung ML, Hsu YT, Chang YH (2006) Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Mt Sinai J Med 73(7):1024–1028

    PubMed  Google Scholar 

  29. Gharagozlian S, Svennevig K, Bangstad H-J, Winberg J-O, Kolset SO (2009) Matrix metalloproteinases in subjects with type 1 diabetes. BMC Clin Pathol 9:7. https://doi.org/10.1186/1472-6890-9-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Wu SC, Driver VR, Wrobel JS, Armstrong DG (2007) Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 3:65–76

    PubMed  PubMed Central  Google Scholar 

  31. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603–1616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kane CD, Greenhalgh DG (2000) Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Repair Regen 8(1):45–45

    Article  CAS  PubMed  Google Scholar 

  33. Davies CE, Wilson MJ, Hill KE et al (2001) Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 9(5):332–340 (Review)

    Article  CAS  PubMed  Google Scholar 

  34. López-Boado YS, Wilson CL, Hooper LV, Gordon JI, Hultgren SJ, Parks WC (2000) Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol 148(6):1305–1315

    Article  PubMed  PubMed Central  Google Scholar 

  35. Maeda H, Okamoto T, Akaike T (1998) Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem 379(2):193–200

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The concept and design of research belong to FKT and GSK. Animal experiments were carried out by FKT and MT, ES preparation by FKT, EP, and SS, RT-PCR was conducted by FKT and EC. TS and EYS carried out the immunohistochemical analysis. FKT, TS, and EYS performed data analysis, interpretation and writing the article, supervised by GSK. This work was supported by the Scientific Research Project Coordination Unit of Istanbul University (Project number: 35048).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gonul Kanigur-Sultuybek.

Ethics declarations

Conflict of interest

All authors stated that there is no conflict of interests that could be perceived as prejudicing the impartiality of the research reported.

Ethical standard statement

All procedures performed in studies involving animals were in accordance with the ethical standards of the Animal Ethical Committee of Istanbul University (Approval no. 2013/39).

Informed consent

For this type of study, formal consent is not required.

Additional information

Managed by Antonio Secchi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tombulturk, F.K., Soydas, T., Sarac, E.Y. et al. Regulation of MMP 2 and MMP 9 expressions modulated by AP-1 (c-jun) in wound healing: improving role of Lucilia sericata in diabetic rats. Acta Diabetol 56, 177–186 (2019). https://doi.org/10.1007/s00592-018-1237-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-018-1237-5

Keywords

Navigation